|
Aortoiliac Infections
According to Rutherford’s Vascular Surgery, “[An] aortic infection is one of the gravest conditions in peripheral vascular surgery.”1 When these situations arise, surgeons require solutions that they can have confidence in. CryoArtery Aortoiliac Artery and Descending Thoracic Aorta are the Natural Choice® for treating aortic infections.
Excellent Resistance to Infection3-7
- 0% Reinfection at 48 months2
Outstanding Durability3
- No reports of aneurysm or dilation of the CryoArtery Aortoiliac Artery in four U.S. studies3-6
Cost Effective7
- The allograft group costs 40% less than the conventional group (p=0.005)7
|
CryoArtery Aortoiliac Artery2 |
In-Situ Fem-Pop Vein Autograft (NAIS)8 |
Axillofemoral Reconstruction9 |
In-Situ Rifampin-Soaked Synthetic Graft10 |
| # of Patients |
21 |
187 |
45 |
27 |
| Median FU (Months) |
48 |
32 |
16 |
17 |
| Graft Reinfection |
0% |
5% |
0% |
11% |
| Mortality (30-Day) |
0% |
10% |
20% |
8% |
| Aneurysmal Degeneration; Dilation |
NR |
0% |
NR |
NR |
References:
1. Rutherford’s Vascular Surgery (7th ed.), Cronenwett J and Johnston K (Eds.). Philadelphia, PA: Saunders Elsevier. 2010;1.
2. Vardanian A, et al. Am Surg 2009;75:1000-3.
3. Brown K, et al. J Vasc Surg 2009;49:660-6.
4. Noel A, et al. J Vasc Surg 2002;35:847-852.
5. Zhou W, et al. Tex Heart Inst J 2006;33:14-8.
6. McCready R, et al. Ann Vasc Surg 2006 Sep;20(5):590-5.
7. Vogt P, et al. J Thorac Cardiovasc Surg 1998;116:965-72
8. Ali A, et al. J Vasc Surg 2009;50:30-9.
9. Liedenbaum M, et al. Worl J Surg 2009;33:2490-2496.
10. Bandyk D, et al. J Surg Res. 2001;95(1):44-9.
|
